DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neggram (Nalidixic Acid) - Published Studies


Neggram Related Published Studies

Well-designed clinical trials related to Neggram (Nalidixic Acid)

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. [2007.03]

A comparative study of genotoxic effects in the treatment of trichomonas vaginalis infection: metronidazole or nalidixic acid. [2000.07]

A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. [2000.07]

Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid. [2000.05]

Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it. [1995.04]

Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial. [1995.01]

Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children. [1994.12]

Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children. [1994.04]

Assessment of the effects of ciprofloxacin and nalidixic acid on cerebral blood flow and metabolism in healthy subjects by positron emission tomography. [1994.03]

Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. [1988.11]

Failure of single-dose metronidazole prophylaxis in colorectal surgery. No benefit from high dosage or combination with nalidixic acid. [1988.04]

Well-designed clinical trials possibly related to Neggram (Nalidixic Acid)

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2011.10.05]

A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. [2011.08]

The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. [2011.06]

Temporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of Vietnam. [2011.01.04]

Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. [2009.08.01]

Effects of a siderophore receptor and porin proteins-based vaccination on fecal shedding of Escherichia coli O157:H7 in experimentally inoculated cattle. [2009.04]

Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). [2008.10.08]

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2008.10.08]

Molting in Salmonella Enteritidis-Challenged Laying Hens Fed Alfalfa Crumbles. I. Salmonella Enteritidis Colonization and Virulence Gene hilA Response. [2007.08]

A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos. [2005.06]

Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children. [2005.03]

Double blind comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever. [2004.03]

Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin. [1999.11]

In vitro susceptibility of new generation of antibacterial antibiotics against pathogenic bacteria. [1999.02]

Increased height gain of children fed a high-protein diet during convalescence from shigellosis: a six-month follow-Up study. [1998.10]

Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori. [1998.10]

[Prevention of reinfection by L-methionine in patients with recurrent urinary tract infection] [1997.10.15]

Short courses of ofloxacin for the treatment of enteric fever. [1997.05]

Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. [1997.03]

Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. [1997.03]

Efficacy of antimicrobial treatment in non-dysenteric persistent diarrhoea in a community setting. [1996.11]

Application of direct-fed microbial bacteria and fructooligosaccharides for salmonella control in broilers during feed withdrawal. [1996.02]

Comparative trial of five antimicrobial compounds in the treatment of cholera in adults. [1995.01]

Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. [1994.12]

[Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose] [1994.06]

Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora. [1994.04]

Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic. [1993.03]

Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial. [1992.09]

Randomized clinical trial of norfloxacin for shigellosis. [1991.12]

Oral zinc supplementation in persistent diarrhoea in infants. [1990.03]

Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole. [1990.02]

Effect of protein rich diet during acute phase of dysentery. [1990.01]

Effect of quinolone antimicrobials on theophylline pharmacokinetics. [1989.07]

Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. [1989.06.01]

Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study. [1987]

Other research related to Neggram (Nalidixic Acid)

Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis. [2008.01]

Efficient approach to acyloxymethyl esters of nalidixic acid and in vitro evaluation as intra-ocular prodrugs. [2006.04.15]

Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents. [2006.02]

Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. [2005.06.21]

Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. [2005.05.18]

Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy. [2004.11]

Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease. [2004.09]

Studies on molecular interactions between nalidixic acid and liposomes. [2004.07.26]

Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease. [2004.07]

The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. [2004.07]

Other possibly related research studies

In-vitro mutagenesis of qnrA and qnrS genes and quinolone resistance in Escherichia coli. [2007.09]

Prevalence and antimicrobial resistance of Campylobacter in US dairy cattle. [2007.06]

Prevalence and antibiotic resistance of Campylobacter spp. isolated from chicken meat, pork, and beef in Korea, from 2001 to 2006. [2007.04]

Evaluation of a survey approach to estimating the prevalence of cattle carrying antimicrobial-resistant Escherichia coli. [2007.04.18]

Antimicrobial resistance among enterobacteriaceae causing uncomplicated urinary tract infections in Mauritius: consequences of past misuse of antibiotics. [2007.04]

Clinical and microbiological investigations of typhoid fever in an infectious disease hospital in Kuwait. [2007.04]

Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. [2007.03]

Typhoid fever: narrowing therapeutic options in India. [2006.11]

Transmission of Escherichia coli O157:H7 to cattle by house flies. [2007.06.15]

Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. [2007.04]

Primary gluteal abscess due to Salmonella typhimurium: a case report and review of the literature. [2007.02]

Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin. [2007.02]

Prevalence of antimicrobial resistance among Salmonella on midwest and northeast USA dairy farms. [2007.05.16]

Diclofenac in the management of E. coli urinary tract infections. [2006.09]

Cefotaxime-ciprofloxacin combination therapy for nontyphoid Salmonella bacteremia and paravertebral abscess after failure of monotherapy. [2006.11]

Antimicrobial resistance in non-typhoidal salmonellas from humans in Northern Ireland, 2001-2003: standardization needed for better epidemiological monitoring. [2007.05]

Antimicrobial resistance profiling and fla-typing of Irish thermophillic Campylobacter spp. of human and poultry origin. [2006.11]

[Comparative susceptibility evolution in Escherichia coli from urinary tract infections in outpatients and inpatients at Perpignan hospital in 2002 and 2004] [2006.10]

Shedding of escherichia coli O157:H7 by cattle fed diets containing monensin or tylosin. [2006.09]

Photosensitized DNA damage and its protection via a novel mechanism. [2007.01]

The effect of feed deprivation on tissue invasion by Salmonella enteritidis. [2006.08]

Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2. [2006.08]

Age-related clinical and microbiological characteristics of enteric fever in India. [2006.10]

Antimicrobial resistance in non-typhoidal Salmonella from human sources, Spain, 2001-2003. [2006.08]

Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. [2006.06]

Prevalence of Clostridium difficile in the environment in a rural community in Zimbabwe. [2006.12]

Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A. [2006.04]

Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates. [2006.05]

Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates. [2006.05]

Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. [2006.05.15]

Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B streptococcus carriage in pregnant women. [2006.03]

Molecular characterisation of bovine faecal Escherichia coli shows persistence of defined ampicillin resistant strains and the presence of class 1 integrons on an organic beef farm. [2006.06.15]

Multidrug resistance and distribution of Salmonella serovars in slaughtered pigs. [2006.02]

Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland. [2005.10]

Outbreak of Shigella sonnei gastroenteritis in Northeastern Taiwan. [2006.01]

Is Campylobacter involved in antibiotic associated diarrhoea? [2005.10]

Nontyphoidal Salmonella from human clinical cases, asymptomatic children, and raw retail meats in Yucatan, Mexico. [2006.01.01]

Epidemiology of typhoid fever in Mauritius. [2005.09]

Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. [2005.12]

Effect of quinolone treatment on selection and persistence of quinolone-resistant Escherichia coli in swine faecal flora. [2005]

Current perspectives of enteric fever: a hospital-based study from India. [2005.09]

Effect of pooling bovine fecal samples on the sensitivity of detection of E. coli O157:H7. [2005.09.30]

Frequency and treatment of urinary tract infection in children subjected to urine culture, in Sana'a, Yemen. [2005.04]

Insertional mutation of marA vitiates inducible multiple antimicrobial resistance in Salmonella enterica subsp. enterica serovar Choleraesuis. [2005.08.30]

Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo. [2005.05]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017